Annual Report 2021

Greiner Packaging is one of Europe’s leading manufacturers of plastic packaging for the food and non-food sector. For over 60 years, the company has been renowned for its high problem-solving competence in development, design, production, and decoration. The company responds to the challenges of the market with two business units: Packaging and Assistec. The product range of the former includes cup packaging as well as packaging solutions such as bottles, containers, and buckets made of plastic and cardboard-plastic combinations. The Assistec business unit focuses on the production of customized plastic parts and products including assembling and individually finishing them.

“IN 2021, WE PROVED OURSELVES TO BE AN EXTREMELY RELIABLE partner FOR OUR CUSTOMERS.”

Manfred Stanek

CEO Greiner Packaging International GmBH

Greiner Packaging is a global player: In the 2021 financial year, the company employed around 4,900 people at 32 locations in 19 countries. Including joint ventures, Greiner Packaging achieved an annual sales revenue of 772 million euros, thus maintaining the previous year’s sensational result in the second year of the pandemic. Both business units improved their revenue and sales thanks to a number of initiatives related to the circular economy and other factors.

Sales revenue in 2021

NEVEON is a leading global integrated foam group, which brings the former portfolio companies Eurofoam, aerospace, MULTIfoam, Unifoam, Perfoam, and PURTEC together under a strong umbrella brand. NEVEON’s three divisions – Living & Care (mattresses, padded furniture, and medical applications), Mobility (automotive, aviation, railway and maritime), and Specialties (boiler insulation, acoustic solutions, filter foams, sport applications, specialized packaging, and other special applications) produce outstanding polyurethane soft and composite foams for a wide range of applications.

Sales revenue in 2021

The Group operated 55 sites in 17 countries in 2021, and employed more than 3,400 people. In the 2021 financial year, i.e., in the first fully consolidated year after the acquisition of Eurofoam, NEVEON increased sales revenue to 735 million euros. This corresponds to an increase of 53.3 percent compared to the previous year*. The result far exceeded our sales revenue targets – despite an extremely challenging economic environment dominated by the effects of the pandemic, the shortage of raw material supplies, the associated price increases, and strained supply chains. NEVEON grew in all its core segments Living & Care, Mobility, and Specialties and strengthened its market positions.

Greiner Bio-One is a global leader in the development and manufacture of single-use plastic products for use in medical, biotechnology, diagnostic and pharmaceutical applications, as well as in vitro diagnostics. Its extensive portfolio is sold in more than 100 countries. Greiner Bio-One uses cutting-edge technologies in its Preanalytics, BioScience, and Mediscan business areas as the basis for excellence in basic research, pharmaceutical drug discovery, pre-analytics, and diagnostics.

“MILLIONS OF VST TUBES ARE USED FOR PCR TESTING AROUND THE WORLD.”

Rainer Perneker

CEO Greiner Bio-One International GmbH

In the 2021 financial year, Greiner Bio-One employed around 2,500 people at 28 locations in 22 countries. Greiner Bio-One improved its sales revenue to 695 million euros in 2021 – a 0.4-percent increase compared to the extremely high figure for 2020, which was 36 percent higher than in 2021. As in 2020, the VACUETTE^® virus stabilization tube (VST) accounted for a large part of the very positive sales growth. Millions of VS tubes with the red screw cap were sold around the world to make sure that samples were transported securely for PCR testing – a significant step in combating the pandemic. However, Greiner Bio-One’s success was not just down to this important product. The good business performance in 2021 was also attributable to increased demand for standard products provided by Preanalytics and BioScience, which both also played an important role in COVID testing and the vaccine development process. These included ELISA microplates, cell culture vessels, and bulk cell culture products.

Sales revenue in 2021

Greiner Extrusion is the world’s leading supplier of extrusion lines, tools, and turnkey equipment for profile extrusion. In the 2021 financial year, the company employed more than 600 people at 13 locations in nine countries. The company was able to finish 2021 with sales revenue of 76 million euros, a significant increase of around 12 percent compared to 2020. This was an outstanding performance in a challenging macroeconomic environment, which was characterized by massive problems in international supply chains as a result of the pandemic, as well as raw material shortages and the associated price increases.

Sales revenue in 2021

After more than 35 years under the Greiner umbrella, Greiner Extrusion was sold at the end of 2021 to the Dutch-German investment company Nimbus. This transaction is based on the belief that the further development and future growth of Greiner Extrusion is best possible in this new environment. Following the sale, Greiner is focusing on its three largest core divisions: Greiner Packaging, Greiner Bio-One, and NEVEON. In addition to holding a majority stake in Greiner Extrusion, Nimbus is the owner of the Battenfeld-Cincinatti Group. Having both companies under the umbrella of a joint holding company makes it possible to leverage synergies in development, production, and sales which would not have been possible under the Greiner umbrella. Thanks to the momentum established in 2021, Greiner Extrusion is entering a new era stronger than ever.